The new program is validated in a set of clinical pedigrees demonstrating its practical accuracy and relevance to the field. Collectively, the data are compelling and support the major conclusions of ...
Vertex ( ($VERX) ) has shared an update. On October 21, 2025, Vertex announced the retirement of David DeStefano as CEO, effective November 10, ...
Vertex said Tuesday that David DeStefano is retiring as president and chief executive, effective Nov. 10. The company added that its board has named Christopher Young as its new president and CEO, ...
A former executive at Microsoft, McAfee and Cisco becomes the fourth CEO in Vertex's 47-year history.
Christopher Young to Succeed David DeStefano as Vertex’s President and Chief Executive OfficerLeadership Transition to Occur on November 10, ...
With a market cap of $104.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company focused on ...